PATENT CLAIM ANALYSIS

Application Number: 15736339
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-05
Patent Classification: ["514", "080000"]

Abstract:
The present invention relates to synergistic pharmaceutical combinations comprising organic arsenoxide compounds and mTOR inhibitors. Further, the present invention relates to the use of these pharmaceutical combinations in therapy, in particular, treatment of proliferative diseases.

Claim (Index 28):
The method according to  claim 25 , wherein the organo-arsenoxide compound, or a pharmaceutically acceptable salt, hydrate, solvate or prodrug thereof, is administered first, followed by the mTOR inhibitor, or a pharmaceutically acceptable salt, hydrate, solvate or prodrug thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13363558', '13586959', '14075597', '12513159', '12505295']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7529707043564361
- 35 USC 102 Novelty (BERT): 0.5263210061216912
- Combined Prediction Score: 0.7303057345329617
- Mean Citation Score: 280.894642
- Max Citation Score: 294.6819799999999
- Similarity Product: 181.27392873725643

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test